HURA (TuHURA Biosciences) Non Operating Income: $-2.27 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HURA TuHURA Biosciences Inc HURA
11 GF Score
Price $2.15
View Full Analysis

What is TuHURA Biosciences Non Operating Income?

TuHURA Biosciences HURA +7.50% 11 Non Operating Income is $-2.27 Mil as of Jun. 2026. GuruFocus rates HURA with a GF Score™ of 11/100.

Non Operating Income is income or expense that comes from miscellaneous sources. TuHURA Biosciences's Non Operating Income for the three months ended in Jun. 2026 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was $-2.27 Mil.

TuHURA Biosciences Non Operating Income Related Terms

TuHURA Biosciences Non Operating Income Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences Non Operating Income Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
0.73 0.29 -16.22 -0.75 -2.27

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.09 -0.50 -1.77 0.00 0.00
HURA
11GF Score
TuHURA Biosciences Inc HURA
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $-2.27 Mil mean?
TuHURA Biosciences (HURA) has a Non Operating Income of $-2.27 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on TuHURA Biosciences and its competitors.
Is TuHURA Biosciences' Non Operating Income too high?
TuHURA Biosciences' current Non Operating Income is $-2.27 Mil. Overall, TuHURA Biosciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Non Operating Income compare to CNTB and CUE?
TuHURA Biosciences' Non Operating Income of $-2.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Biotechnology company?
A good Non Operating Income depends on the Biotechnology industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on TuHURA Biosciences and its competitors. TuHURA Biosciences's current Non Operating Income is $-2.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current Non Operating Income of $-2.27 Mil. The current Non Operating Income is $-2.27 Mil. TuHURA Biosciences' overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current Non Operating Income is $-2.27 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
11GF Score

Get the complete analysis for HURA

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price